EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Performance of anti-SARS-CoV-2 IgG/IgM rapid diagnostic test in N'Djamena, Chad: evidence from a clinical prespective during an outbreak response

Joseph Fokam

Sahelian Journal of Responsible One Health · 2025

DOI: 10.4081/sjroh.2025.557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sahelian Journal of Responsible One Health, 2025. Verfasst von Joseph Fokam. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The utility of rapid serological tests for anti-SARS-CoV-2 antibodies, particularly in a tropical context, is not well-defined. We evaluated the performance of the GENRUI Biotech Inc IgG/IgM rapid diagnostic test (RDT) against an ELISA as the gold standard.

Methods

This was a cross-sectional study in N’djamena, Chad, in July 2022. A total of 198 samples from individuals attending a facility for COVID-19 diagnosis were tested using both the GENRUI RDT and the DIATHEVA COVID-19 IgG ELISA kit.

Results

IgG seropositivity with ELISA was 84.8%, significantly higher than the 54% found with the RDT, representing a 30.8% difference. The RDT showed a sensitivity of 60% and a specificity of 80%, with poor agreement with ELISA (Cohen Kappa=0.22). Positive and negative predictive values were 94% and 26% respectively.

Conclusions

The rapid IgM/IgG test from GENRUI Biotech Inc. has a significantly suboptimal performance for detecting anti-SARS-CoV-2 antibodies. This highlights the need for performing ELISA on non-reactive RDT cases during sero-surveys or post-vaccine response assessment.

Zitieren

APA

Fokam, J. (2025). Performance of anti-SARS-CoV-2 IgG/IgM rapid diagnostic test in N'Djamena, Chad: evidence from a clinical prespective during an outbreak response. Sahelian Journal of Responsible One Health. https://doi.org/10.4081/sjroh.2025.557

Vancouver

Fokam J. Performance of anti-SARS-CoV-2 IgG/IgM rapid diagnostic test in N'Djamena, Chad: evidence from a clinical prespective during an outbreak response. Sahelian Journal of Responsible One Health. 2025. doi:10.4081/sjroh.2025.557

BibTeX
@article{Fokam2025,
  author = {Fokam, Joseph},
  title = {Performance of anti-SARS-CoV-2 IgG/IgM rapid diagnostic test in N'Djamena, Chad: evidence from a clinical prespective during an outbreak response},
  journal = {Sahelian Journal of Responsible One Health},
  year = {2025},
  doi = {10.4081/sjroh.2025.557}
}
Kostenlos starten →